Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis

American Heart Journal

Volumn 165, Issue 4, 2013, Pages

  Vedantham, Suresh ^a   Goldhaber, Samuel Z ^b   Kahn, Susan R ^c   Julian, Jim ^d   Magnuson, Elizabeth ^e   Jaff, Michael R ^f   Murphy, Timothy P ^g   Cohen, David J ^e   Comerota, Anthony J ^h   Gornik, Heather L ⁱ   Razavi, Mahmood K ^j   Lewis, Lawrence ^k   Kearon, Clive ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j St Joseph's Vascular Institute   (United States)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MECHANICAL THROMBECTOMY; MULTICENTER STUDY (TOPIC); PATIENT SAFETY; PHARMACOMECHANICAL CATHETER DIRECTED THROMBOLYSIS; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THERAPY EFFECT;

EID: 84875461378     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.01.024     Document Type: Article

References (30)

1. S.R. Kahn, I. Shrier, and J.A. Julian Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis Ann Intern Med 149 2008 698 707
2. S.R. Kahn, H. Shbaklo, and D.L. Lamping Determinants of health-related quality of life during the 2 years following deep vein thrombosis J Thromb Haemost 6 2008 1105 1112
3. R. Guanella, T. Ducruet, and M. Johri Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation J Thromb Haemost 9 12 2011 2397 2405
4. C. Kearon, E.A. Akl, and A.J. Comerota Antithrombotic therapy for VTE disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2 2012 e419S e494S
5. M.H. Meissner, R.A. Manzo, and R.O. Bergelin Deep venous insufficiency: the relationship between lysis and subsequent reflux J Vasc Surg 18 1993 596 608
6. R.D. Hull, V.J. Marder, and A.F. Mah Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: a systematic review Am J Med 118 5 2005 456 464
7. P. Prandoni, M. Frulla, and D. Sartor Venous abnormalities and the post-thrombotic syndrome J Thromb Haemost 3 2005 401 402
8. H. Arnesen, A. Hoiseth, and B. Ly Streptokinase or heparin in the treatment of deep vein thrombosis Acta Med Scand 211 1982 65 68
9. A.G.G. Turpie, M.N. Levine, and J. Hirsh Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis: results of a randomized trial Chest Suppl 97 4 1990 172S 175S
10. G. Plate, H. Akesson, and E. Einarsson Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula Eur J Vasc Surg 4 1990 483 489
11. T. Enden, Y. Haig, and N. Klow Long-term outcomes after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial Lancet 379 9810 2012 31 38
12. S. Vedantham, C.J. Grassi, and H. Ferral Reporting standards for endovascular treatment of lower extremity deep vein thrombosis J Vasc Interv Radiol 17 2006 417 434
13. U.S. Department of Health and Human Services. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. September 15, 2008.
14. M. Roumen-Klappe den Heijer, and J. van Rossum Multilayer compression bandaging in the acute phase of deep-vein thrombosis has no effect on the development of the post-thrombotic syndrome J Thromb Thrombolysis 27 4 2009 400 405
15. S. Vedantham, P.E. Thorpe, and J.F. Cardella Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal J Vasc Interv Radiol 17 2006 435 447
16. S.R. Kahn, S. Desmarais, and T. Ducruet Comparison of performance of two clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and valvular reflux J Thromb Haemost 4 4 2006 907 908
17. S.R. Kahn, H. Partsch, and S. Vedantham Definition of post-thrombotic syndrome in the leg for use in clinical investigations: a recommendation for standardization J Thromb Haemost 7 2009 879 883
18. S.R. Kahn Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome J Thromb Haemost 7 5 2009 884 888
19. P. Prandoni, A.W. Lensing, and M.H. Prins Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial Ann Intern Med 141 2004 249 256
20. S.R. Kahn, C. Kearon, and J.A. Julian Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis J Thromb Haemost 3 2005 718 723
21. S. Villalta, P. Prandoni, and A. Cogo The utility of non-invasive tests for detection of previous proximal-vein thrombosis Thromb Haemost 73 1995 592 596
22. D.N. Kolbach, H.A.M. Neumann, and M.H. Prins Definition of the post-thrombotic syndrome, differences between existing classifications Eur J Vasc Endovasc Surg 30 2005 404 414
23. B. Eklof, R.B. Rutherford, and J.J. Bergan Revision of the CEAP classification for chronic venous disorders: consensus statement J Vasc Surg 40 2004 1248 1252
24. M.H. Meissner, C. Natiello, and S.C. Nicholls Performance characteristics of the venous clinical severity score J Vasc Surg 36 2002 889 895
25. S.R. Kahn, T. Ducruet, and D.L. Lamping The VEINES-QOL/Sym questionnaire is a valid and reliable measure of quality of life and symptoms in patients with deep vein thrombosis J Clin Epidemiol 59 10 2006 1049 1056
26. V.J. Marder, R.L. Soulen, and V. Atichartakarn Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy J Lab Clin Med 89 5 1977 1018 1029
27. J. Brazier, J. Roberts, and M. Deverill The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 2 2002 271 292
28. J.R. Beck, and S.G. Pauke The Markov process in medical prognosis Med Decis Making 3 4 1983 419 458
29. M.A. Ricci, J. Emmerich, and P.W. Callas Evaluating chronic venous disease with a new venous severity scoring system J Vasc Surg 38 2003 909 915
30. M.R. Jaff, M.S. McMurtry, and S.L. Archer Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association Circulation 123 16 2011 1788 1830